BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10437880)

  • 1. "Inactive" polymer is active against sexually transmitted diseases.
    Larkin M
    Lancet; 1999 Jul; 354(9176):399. PubMed ID: 10437880
    [No Abstract]   [Full Text] [Related]  

  • 2. [The acceptability on vaginal microbicides to prevent human immunodeficiency virus/sexually transmitted diseases].
    Han L; Wu ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):196-8. PubMed ID: 19565887
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenges of introducing vaginal microbicides in India.
    Joshi S; Kulkarni V; Paranjape R; Chandhiok N
    Indian J Med Res; 2009 May; 129(5):618-9. PubMed ID: 19675395
    [No Abstract]   [Full Text] [Related]  

  • 4. Microbicides: putting women in control.
    Forbes A
    WORLD; 1998 Sep; (89):4-5. PubMed ID: 11365770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.
    Nikolic DS; Garcia E; Piguet V
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivering on MPTs: addressing the needs, rising to the challenges and making the opportunities.
    Malcolm RK; Fetherston SM
    Contraception; 2013 Sep; 88(3):321-5. PubMed ID: 23890794
    [No Abstract]   [Full Text] [Related]  

  • 7. Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.
    Neurath AR; Strick N; Li YY; Lin K; Jiang S
    Biologicals; 1999 Mar; 27(1):11-21. PubMed ID: 10441398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbicide for prevention of sexually transmitted diseases using a pharmaceutical excipient.
    Neurath AR
    AIDS Patient Care STDS; 2000 Apr; 14(4):215-9. PubMed ID: 10806641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbicides for the prevention of sexually transmitted HIV infection.
    Karim QA; Baxter C
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):13-23. PubMed ID: 23428099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035.
    Richardson BA; Kelly C; Ramjee G; Fleming T; Makanani B; Roberts S; Musara P; Mkandawire N; Moench T; Coletti A; Soto-Torres L; Karim SA;
    J Acquir Immune Defic Syndr; 2013 May; 63(1):120-5. PubMed ID: 23334506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
    Joanis CL; Hart CW
    AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe.
    van der Straten A; Napierala S; Cheng H; Mauck C; Depineres T; Dhlakama P; Thompson M; Chipato T; Hammond N; Padian N
    Contraception; 2007 Nov; 76(5):389-99. PubMed ID: 17963865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'We need a microbicide now!'.
    Smart T
    IAPAC Mon; 2006 Apr; 12(4):114. PubMed ID: 17233098
    [No Abstract]   [Full Text] [Related]  

  • 14. Unacceptable side-effects associated with a hyperosmolar vaginal microbicide in a phase 1 trial.
    Lacey CJ; Woodhall S; Qi Z; Sawant S; Cowen M; McCormack S; Jiang S
    Int J STD AIDS; 2010 Oct; 21(10):714-7. PubMed ID: 21139151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbicides now.
    Forrest S
    Posit Living; 2001 Apr; 10(3):31-3, 38. PubMed ID: 11548374
    [No Abstract]   [Full Text] [Related]  

  • 16. A cause for optimism: microbicides pipeline shows promise.
    McCord A
    Proj Inf Perspect; 2008 Sep; (46):24-5. PubMed ID: 19048680
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men.
    Jespers V; Buvé A; Van Damme L
    Sex Transm Dis; 2007 Jul; 34(7):519-22. PubMed ID: 17297382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The slow evolution of microbicides for STD/HIV prevention.
    Howes J; Bass M
    J Gend Specif Med; 1999; 2(3):22-3. PubMed ID: 11252848
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections.
    Ndesendo VM; Pillay V; Choonara YE; Buchmann E; Bayever DN; Meyer LC
    AAPS PharmSciTech; 2008; 9(2):505-20. PubMed ID: 18431651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research. Spun cloth may provide another option for HIV protection.
    AIDS Policy Law; 2013 Jan; 28(3):3. PubMed ID: 23476951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.